For rectal cancer, which imaging modality is better for surgical planning—MRI or CT?
Sep 03, 2021
Source: Cainiu Health
Introduction
MRI offers excellent tissue resolution, enabling superior visualization of the rectal wall and surrounding infiltrative changes, making it the most effective imaging modality for comprehensive clinical diagnosis, treatment planning, and prognostic assessment of rectal cancer. The European Society for Medical Oncology (ESMO) recommends MRI as the first-line imaging modality for staging T2, T3, and T4 tumors—as well as for evaluating lymph node metastasis—except for T1 tumors, for which endorectal ultrasound is preferred.
MRI offers excellent soft-tissue resolution, enabling superior visualization of the rectal wall and surrounding infiltrative changes, making it the most effective imaging modality for comprehensive clinical diagnosis, treatment planning, and prognostic assessment of rectal cancer.

The European Society for Medical Oncology (ESMO) recommends endorectal ultrasound as the first-line imaging modality for T1 tumors; however, for tumor staging of T2, T3, and T4 lesions—as well as nodal staging—MRI is the preferred initial imaging examination. Computed tomography (CT) may be used only as an alternative when assessing mesorectal fascia involvement or nodal staging.